Our Services

With experience, insight, and extensive knowledge of market and economic forces, Quorum Consulting delivers answers that work for our clients—repeatedly.

Sales Volume
Development
Introduction
Growth
Maturity
Health Economics and Outcomes Research
Market Access
Reimbursement Policy and Government Affairs
Strategic Product Planning
Time

Strategic Product Planning

Developing comprehensive market access, evidence, and pricing strategies that are actionable and leverage insights from payers, physicians, and other stakeholders.

 

Mr. Graham works with clients to identify and demonstrate the value of life science innovation to influence product adoption across key stakeholders.

Team Bios

Mr. Scott develops actionable strategies that address payer requirements and drive provider adoption, ultimately enabling widespread access for novel technologies.

Team Bios

Reimbursement Policy and Government Affairs

Working with relevant and influential authorities to craft informed coverage policy and secure codes and payment that support appropriate and effective technology applications.

 

Ms. Littmann brings over 15 years of implementing customer and field programs to novel programs for niche markets and disruptive technologies.

Team Bios

Health Economics and Outcomes Research

Developing the evidence necessary to optimize product adoption, coverage, and reimbursement – from developing the premise and analysis plan to carrying out the requisite research or building models for various payer or customer audiences, including exploring nontraditional and mixed-methods pathways.

 

Dr. Arnold is a pioneer in the development and use of HEOR methods in comparative effectiveness research. In particular, Dr. Arnold has developed and promoted use of real-world evidence to support coverage and payment decisions in and outside of the US.

Team Bios

Mr. Layton specializes in analyzing data and applying analytics to reimbursement policy initiatives. He has extensive experience working with providers on data collection, profitability analyses, and operational efficiency analysis.

Team Bios

This cost-of-care analysis assesses open-angle glaucoma costs over 5 years after initial treatment with two trabecular micro-bypass stents (iStents), selective laser trabeculoplasty (SLT), or medications only.

publication

In a study using 5% Medicare Standard Analytical Files, post-creation procedures and associated costs for surgically created hemodialysis arteriovenous fistulas (AVF) were found to be statistically significantly greater than those for a new endovascularly created AVF.

publication

Market Access

Applying innovation to the design of reimbursement hotlines, appeal case management programs, and responsive customer and field team arrangements, as well as creating reliable, consistent feedback loops to support your broader market access strategies.

 

Ms. Littmann brings over 15 years of implementing customer and field programs to novel programs for niche markets and disruptive technologies.

Team Bios

Request a Consultation